stella
beta
Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases — Stella
Recruiting
Back to Neuroendocrine Tumor trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(4 sites)
France
Institut Bergonié, Bordeaux
Institut de cancérologie du Gard (ICG) - CHU de Nîmes, Nîmes
CHU Bordeaux - Hôpital Haut Lévêque, Pessac
Institut universitaire du cancer de Toulouse (IUCT) Oncopole, Toulouse
View full record on ClinicalTrials.gov